Verrica Pharmaceuticals Inc. (VRCA)

CIK 1660334 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Verrica Pharmaceuticals Inc..

Recent SEC filings

FiledFormAccession number
Aug 18, 202640002043558-26-000005
Aug 18, 202640002046750-26-000004
Aug 18, 202640001579649-26-000005
Aug 18, 202640001556327-26-000003
Aug 6, 202610-Q0001660334-26-000025
Aug 6, 20268-K0001193125-26-338273
Jun 9, 202640001814338-26-000002
Jun 9, 202640002046750-26-000002
Jun 9, 202640001579649-26-000002
Jun 9, 202640001257544-26-000002
Jun 9, 202640002043558-26-000002
Jun 9, 202640001814892-26-000002
Jun 9, 20268-K0001193125-26-263722
Jun 9, 202640001745995-26-000002
May 12, 2026S-80001193125-26-219912
May 12, 20268-K0001193125-26-219395
May 12, 202610-Q0001660334-26-000014
Apr 20, 2026ARS0001193125-26-164036
Apr 20, 2026DEFA14A0001193125-26-164025
Apr 20, 2026DEF 14A0001193125-26-163961
Mar 11, 20268-K0001193125-26-101126
Mar 11, 202610-K0001660334-26-000008
Feb 17, 2026SCHEDULE 13G/A0001172661-26-001229
Feb 2, 20263/A0002101167-26-000004
Jan 29, 2026SCHEDULE 13G/A0001315863-26-000100